Mankind Pharma Limited IPO Message Board (Page 50)

GMP fallen to 88

latest premium 81, falling,

Mankind pharma have one of the highest number of medical representative...(u know how they work if u have family member who is medical general practioner...)))

so don't be surprised if u find here

"SOME OF HIDDEN P.R.AGENTS "....

so take decision according to ur knowledge,reserch nd risk appetite....

Ohh ..Thanks for your words of CAUTION 🙏

@Hope is life 
It is rather easy. You know number of post by a person. You are giving a sweeping judgement on opposite views

Cipla, Dr. Reddys and Aurobindo Pharma are quoting at cheaper valuations than Mankind Pharma. Only Sun Pharma is quoting at higher valuation.

Sir mankind has 97% if revenues from india (from rhp). Cipla,reddy, aurobindo has north america as major chunk of revenues. US FDA has stricter rules in place for such companies, but for mankind it will be not.
Ps- im just stating facts, not in favor/against of the ipo. Neutral🙏

Cons:-

1) very big size, you can see in past 2 years only nykka was able to give listing gain, though its GMP was almost double and market was on bull run on that phase

2) too many grey deals happening, all grey dealers will be there on pre open to sell on lower circuits from 9.01 AM
3) GMP is 8-9 %, also don't know weather its going to sustain
4) USK was small size and GMP was 30% still listed on 15% discount, so this much big issue with 8-9% GMP is risky
5) Market sentiment in mainboard not good

Pros:-

You can sell and Apply

So moral is though GMP is 8-9% its a risky bet, don't follow only GMP blindly

"Dikhavo pe mat Jav, Apni akal lagav"

Any one dealing in grey market?

Capital Market rated Avoid.

In the past 4 IPOs what ever he said avoid or below 44 all have done good and avalon -51 did very bad so it clearly tells anything can happen irrespective of their review.

Capital market rated 44 - High risk high return..

It is a pure OFS, it means company will not get anything in this IPO. The existing shareholders like Ramesh Juneja, Rajeev Junega, Sheeta Arora and Some funds are selling shares worth Rs.4300 Crores in this IPO.

Promoters ki Chandi hi Chandi on behalf of investors. 🤣😂😋🥰😝😜

sold & apply

Gmp 95-96

Ipca Lab is acquiring 33.4% stake of Unichem Lab and intends to come out with open offer at Rs. 440/- per share. Who will be eligible for this open offer ? Any record date fixed for this purpose please ?

everyone should take decision to apply or avoid IPO according to his risk appetite nd knowledge...

but just one advise cum request to

see MEMBERS or BROKERS REVIEW SECTION of UDAYSHIVAKUMAR usk IPO..

it will help u all so much....to decide whether apply or avoid this ipo...

Subscription Figure Estimate

QIB - 7-9 x
Bhni 1-1.1
SNI - 4.5 - 5.5
RETAIL - 1.5X

If premium will stable around 90 or upward

If premium will crash then all this figure will be more downside.

perfect mamu..🫵

QIB will be more than 20X

Mankind Pharma IPO

Closing Bhav (24/April)

95/98
10000₹
2200₹
650/750
Subject to ₹65

Yr comments are highly appreciated it always helped us thks a lot mam 🙏

Mankind Pharma IPO

GMP 96 +/- 1
&
10L Applic. 11,200 +/- 100

Last Heard

@Peter & @MemberHater , Everyone using their own abilities. Posting GMP is the direction to decide, apply or not for listing gain. As many ipos currently even at a premium before listing day and open in a discount. So no fundamental works here specially in listing. Only Myth is GMP.
After 3-6 month of listing, fundamental will decide to hold in portfolio or not.
Peter instead of crisis someone do post your own analysis, gmp or info regarding same.

@MAMU thanks for your advice and this is the best explanation I've got about GMP.

I've now realized I went over the board with my criticism so my apologies, just trying to inform fellow members that GMP should be used very carefully while taking decision about the IPO application.

Also I don't consider myself qualified enough to post my analysis and got no connection to grey market but I try to post my decision about the application, allotment and listing day action as one of the retail investor.

Gmp crossed 100 finally 🚀🔥

@Expert IPO- lockdown was there just before listing of SBI Cards & It lead to market crash. Otherwise it will open atleast with 30-40% premium.

I sold Applications @Kostak- 2900/-.
You generally will not see such high kostak rates on IPO's.

SBI cards bhai aaj bhi apne issue price sr neeche h ….yaha bht sare influencers h samjh baat ko. Who are selling this IPO.

M insiders source ki baat kr rha hun. Yeh dubayega

Max 1.5 times in bhni for 1lot

Bhai sahi he yar tumhare grey market dealers raat ke 11 baje premium batate he
Please update only Genuine premiums

@newgen consultancy 95 pe buyer hai and 98 pe seller.
Accha volume ho raha hai.

@GrayIsTheNewBlack Thank you bhai

Will SBI release the QuickTech money in time for Mankind application ??

Costly ipo. After listing you will get
below issue price.

The TTM EPS on post-issue equity works out to Rs 29.62. At the upper price band of Rs 1080, P/E works out to 36.46.

As of 23 April 2023, its listed peers such as Pfizer India traded at TTM P/E of 29.91, and Eris Lifesciences traded at TTM P/E of 21.02. For FY2022, Mankind Pharma OPM and ROE stood at 25.57% and 23.29%, respectively, compared to 32.01% and 21.38% for Pfizer India, 36% and 21.28% for Eris Lifesciences, respectively.
SOURCE - Capital Market.

@IPO Hater 
Surprised that you compared Eris with this issue. Neither the market cap or profit compares any where close